481 FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

2011 ◽  
Vol 54 ◽  
pp. S197 ◽  
Author(s):  
J.M. Vierling ◽  
E.J. Lawitz ◽  
F. Poordad ◽  
M.S. Sulkowski ◽  
M. Bourliere ◽  
...  
2011 ◽  
Vol 140 (5) ◽  
pp. S-908
Author(s):  
Steven L. Flamm ◽  
Rajender Reddy ◽  
Michael W. Fried ◽  
Geoffrey M. Dusheiko ◽  
David R. Nelson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document